Crinetics Pharmaceuticals, Inc. (CRNX)
CRNX · Pharmaceutical Preparations · San Diego, CA · filing with the SEC since 2015
Filings
333 filings since 2017 beside 393 insider forms · Large accelerated filer · read from EDGAR on Nov 13, 2026Due nextLarge accelerated filer
10-K
Annual report for the fiscal year ending Dec 31, 2026Large accelerated filers have 60 days after the fiscal year ends.
by Mar 1, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 34 days after the quarter ended. The proxy statement was last filed Apr 29, 2026.
Filings a yearinsider forms included
425172908814777107
2026 counts to Nov 13, 2026.
Listing warning from its exchange (8-K item 3.01): 1 time in the last 36 months, the newest Sep 1, 2026.Officer or director change (8-K item 5.02): 12 times in the last 36 months, the newest Sep 1, 2026.Auditor change (8-K item 4.01): 1 time in the last 36 months, the newest Mar 3, 2026.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Sep 1, 2026
8-K items 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 9.01
Major agreement ended; Purchase or sale of a business completed; Listing warning from its exchange; Change to shareholders' rights; Change of control; Officer or director change; Charter, bylaw or fiscal-year change · Current report
Jul 10, 2026
8-K items 1.01, 5.02
Major agreement signed; Officer or director change · Current report
Jul 6, 2026
40 of 333 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.